Your browser doesn't support javascript.
loading
An Nfil3-Zeb2-Id2 pathway imposes Irf8 enhancer switching during cDC1 development.
Bagadia, Prachi; Huang, Xiao; Liu, Tian-Tian; Durai, Vivek; Grajales-Reyes, Gary E; Nitschké, Maximilian; Modrusan, Zora; Granja, Jeffrey M; Satpathy, Ansuman T; Briseño, Carlos G; Gargaro, Marco; Iwata, Arifumi; Kim, Sunkyung; Chang, Howard Y; Shaw, Andrey S; Murphy, Theresa L; Murphy, Kenneth M.
Afiliação
  • Bagadia P; Department of Pathology and Immunology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA.
  • Huang X; Department of Pathology and Immunology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA.
  • Liu TT; Department of Pathology and Immunology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA.
  • Durai V; Howard Hughes Medical Institute, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA.
  • Grajales-Reyes GE; Department of Pathology and Immunology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA.
  • Nitschké M; Department of Pathology and Immunology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA.
  • Modrusan Z; Research Biology, Genentech, South San Francisco, CA, USA.
  • Granja JM; Department of Molecular Biology, Genentech, South San Francisco, CA, USA.
  • Satpathy AT; Center for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, CA, USA.
  • Briseño CG; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
  • Gargaro M; Biophysics Program, Stanford University School of Medicine, Stanford, CA, USA.
  • Iwata A; Center for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, CA, USA.
  • Kim S; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
  • Chang HY; Department of Oncology, Amgen Inc., South San Francisco, CA, USA.
  • Shaw AS; Department of Experimental Medicine, University of Perugia, Perugia, Italy.
  • Murphy TL; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Murphy KM; Department of Pathology and Immunology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA.
Nat Immunol ; 20(9): 1174-1185, 2019 09.
Article em En | MEDLINE | ID: mdl-31406377
ABSTRACT
Classical type 1 dendritic cells (cDC1s) are required for antiviral and antitumor immunity, which necessitates an understanding of their development. Development of the cDC1 progenitor requires an E-protein-dependent enhancer located 41 kilobases downstream of the transcription start site of the transcription factor Irf8 (+41-kb Irf8 enhancer), but its maturation instead requires the Batf3-dependent +32-kb Irf8 enhancer. To understand this switch, we performed single-cell RNA sequencing of the common dendritic cell progenitor (CDP) and identified a cluster of cells that expressed transcription factors that influence cDC1 development, such as Nfil3, Id2 and Zeb2. Genetic epistasis among these factors revealed that Nfil3 expression is required for the transition from Zeb2hi and Id2lo CDPs to Zeb2lo and Id2hi CDPs, which represent the earliest committed cDC1 progenitors. This genetic circuit blocks E-protein activity to exclude plasmacytoid dendritic cell potential and explains the switch in Irf8 enhancer usage during cDC1 development.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Dendríticas / Elementos Facilitadores Genéticos / Fatores Reguladores de Interferon / Fatores de Transcrição de Zíper de Leucina Básica / Proteína 2 Inibidora de Diferenciação / Homeobox 2 de Ligação a E-box com Dedos de Zinco Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Dendríticas / Elementos Facilitadores Genéticos / Fatores Reguladores de Interferon / Fatores de Transcrição de Zíper de Leucina Básica / Proteína 2 Inibidora de Diferenciação / Homeobox 2 de Ligação a E-box com Dedos de Zinco Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article